Get started
AnaptysBio, Inc.
Long

FDA Approves JEMPERLI (dostarlimab-gxly) for dMMR Endometrial Ca

By RocketTickers
ANAB: AnaptysBio, Inc.
2021-04-22 16:12:09
FDA Approves JEMPERLI (dostarlimab-gxly) for dMMR Endometrial Cancer
Beyond Technical Analysis
RocketTickers

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.